Careers
Contact Us
Search and Filter
Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign

After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign

News Releases - May 18, 2022
Increased support needed for a coordinated global HIV and COVID-19 response

Increased support needed for a coordinated global HIV and COVID-19 response

News Releases - March 23, 2022
Trial of innovative HIV vaccine using mRNA technology enrolls first participant

Trial of innovative HIV vaccine using mRNA technology enrolls first participant

News Releases - March 14, 2022
Preliminary findings from studies in South Africa indicate that Omicron has a much higher rate of asymptomatic 'carriage' than other variants of concern

Preliminary findings from studies in South Africa indicate that Omicron has a much higher rate of asymptomatic 'carriage' than other variants of concern

News Releases - January 07, 2022
Faith initiative expands to help build bridges between community and HIV vaccine trials

Faith initiative expands to help build bridges between community and HIV vaccine trials

News Releases - December 14, 2021
Landmark COVID-19 Vaccine Trial in Sub-Saharan Africa is the first to study the efficacy of MRNA COVID-19 vaccines in people living with HIV

Landmark COVID-19 Vaccine Trial in Sub-Saharan Africa is the first to study the efficacy of MRNA COVID-19 vaccines in people living with HIV

News Releases - December 13, 2021
Study participants feel good when helping others, HVTN analysis shows

Study participants feel good when helping others, HVTN analysis shows

News Releases - December 01, 2021
HVTN Remembers Dr. Scott Hammer

HVTN Remembers Dr. Scott Hammer

News Releases - November 19, 2021
Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

News Releases - August 31, 2021
Antibody Mediated Prevention (AMP) Trials Data Published by the New England Journal of Medicine

Antibody Mediated Prevention (AMP) Trials Data Published by the New England Journal of Medicine

Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains
News Releases - March 17, 2021
Harmonizing efforts to conduct large scale COVID-19 vaccine efficacy trials

Harmonizing efforts to conduct large scale COVID-19 vaccine efficacy trials

News Releases - July 09, 2020
HVTN participates in 23rd international AIDS conference (virtual)

HVTN participates in 23rd international AIDS conference (virtual)

News Releases - July 01, 2020
Skilled partners in the conduct of HIV prevention trials join COVID-19 response

Skilled partners in the conduct of HIV prevention trials join COVID-19 response

News Releases - May 14, 2020
Fred Hutch and NIH experts outline plan for COVID-19 vaccines

Fred Hutch and NIH experts outline plan for COVID-19 vaccines

News Releases - May 11, 2020
The HVTN and HPTN remember Gita Ramjee

The HVTN and HPTN remember Gita Ramjee

News Releases - April 01, 2020
Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, April 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, April 2020

News Releases - April 01, 2020
Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

News Releases - March 23, 2020
Experimental HIV vaccine regimen ineffective in preventing HIV

Experimental HIV vaccine regimen ineffective in preventing HIV

News Releases - February 03, 2020
HVTN study confirms correlates of risk associated with decrease in HIV transmission

HVTN study confirms correlates of risk associated with decrease in HIV transmission

News Releases - October 31, 2019
HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

News Releases - October 01, 2019